{"mainPropery":{"diseaseId":12036,"diseaseName":"Facial onset sensory and motor neuronopathy","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/12036/facial-onset-sensory-and-motor-neuronopathy","synonyms":["Facial onset sensorimotor neuronopathy syndrome","FOSMN syndrome","Facial onset sensory and motor neuronopathy syndrome"],"synonyms-with-source":[{"name":"Facial onset sensorimotor neuronopathy syndrome","source":"PMID: 22922575 "},{"name":"FOSMN syndrome","source":"Orphanet"},{"name":"Facial onset sensory and motor neuronopathy syndrome","source":"PMID: 24643461"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"85162"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":3977,"resourceName":"FOSMN Patients Foundation","abbreviation":"","address1":"","address2":"","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"","phone":"","tty":"","tollFree":"","fax":"","email":"https://fosmn.org/contact/","url":"https://fosmn.org/","freeText":""}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=Facial+onset+sensory+motor+neuronopathy+syndrome' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Facial onset sensory and motor neuronopathy. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1530,"resourceId":2161,"resourceName":"National Institute of Neurological Disorders and Stroke (NINDS)","descriptionText":"The <a href='https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Motor-Neuron-Diseases-Fact-Sheet' target='_blank'>National Institute of Neurological Disorders and Stroke (NINDS)</a> (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on&nbsp;this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=85162' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/Orphanet:85162' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":11346,"questionText":"What is facial onset sensory and motor neuronopathy?","answerText":"<strong>Facial onset sensory and motor neuronopathy (FOSMN) </strong>is a rare and slowly progressive <a href=\"https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Motor-Neuron-Diseases-Fact-Sheet\" target=\"_blank\">motor neuron disorder</a>. Affected people initially experience facial tingling and numbness which eventually spread to the scalp, neck, upper trunk and upper limbs. These sensory abnormalities are later followed by the onset of motor symptoms such as cramps, muscle twitches, difficulty swallowing, <a href=\"https://medlineplus.gov/ency/article/007470.htm\" target=\"_blank\">dysarthria</a>, muscle weakness and atrophy. The hallmark of FOSMN is a reduced or absent corneal reflex (the reflex to blink when something touches the eye). The underlying cause is currently unknown. Most cases appear to occur <a href=\"http://www.ncbi.nlm.nih.gov/books/NBK5191/def-item/sporadic/\" target=\"_blank\">sporadically</a> in people with no family history of the condition. Although there is no consensus regarding the best treatment options for FOSMN, some&nbsp;affected people have&nbsp;temporary improvement in response to <a href=\"https://www.uptodate.com/contents/intravenous-immune-globulin-ivig-beyond-the-basics\" target=\"_blank\">intravenous immunoglobulin</a> or <a href=\"https://www.mda.org/sites/default/files/publications/Facts_Plasmapheresis_P-206.pdf\" target=\"_blank\">plasmapheresis</a>.[12648][12649][12650]","dateModified":"2016-11-22T14:56:00"},"basicQuestions":[{"questionId":11348,"questionText":"What are the signs and symptoms of facial onset sensory and motor neuronopathy?","answerText":"Signs and symptoms of facial onset sensory and motor neuronopathy (FOSMN) generally become apparent by age 54 (range 38-77 years) and vary significantly from person to person. The earliest symptoms include facial tingling and numbness which eventually spread to the scalp, neck, upper trunk and upper limbs. These sensory abnormalities often present months to years prior to the development of motor symptoms such as cramps, muscle twitches, difficulty swallowing, <a href=\"https://medlineplus.gov/ency/article/007470.htm\" target=\"_blank\">dysarthria</a>, muscle weakness and atrophy. The hallmark of FOSMN is the reduced or absence of the corneal reflex (the reflex to blink when something touches the eye).[12648][12649][12650]","dateModified":"2016-11-23T15:32:00","resourceClassificationName":"Symptoms","references":[{"referenceId":12648,"authors":"Zheng Q1, Chu L, Tan L, Zhang H","articleTitle":"Facial onset sensory and motor neuronopathy","bookWebsiteJournalTitle":"Neurol Sci","date":"December 2016","volume":"37(12)","pages":"1905-1909","url":"","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12649,"authors":"Ziso B, Williams TL, Walters RJ, Jaiser SR, Attems J, Wieshmann UC, Larner AJ, Jacob A","articleTitle":"Facial Onset Sensory and Motor Neuronopathy: Further Evidence for a TDP-43 Proteinopathy","bookWebsiteJournalTitle":"Case Rep Neurol","date":"April 2015","volume":"7(1)","pages":"95-100","url":"","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12650,"authors":"Fluchere F, Verschueren A, Cintas P, Franques J, Serratrice J, Weiller PJ, Azulay JP, Pouget J, Attarian S","articleTitle":"Clinical features and follow-up of four new cases of facial-onset sensory and motor neuronopathy","bookWebsiteJournalTitle":"Muscle Nerve","date":"Jan 2011","volume":"43(1)","pages":"136-140","url":"","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":11355,"questionText":"What causes facial onset sensory and motor neuronopathy?&nbsp;&nbsp;&nbsp;","answerText":"The underlying cause of facial onset sensory and motor neuronopathy (FOSMN) is currently unknown. Because the clinical features and severity of the condition can vary significantly from person to person, it is thought that there may be a <a href=\"http://ghr.nlm.nih.gov/handbook/mutationsanddisorders/complexdisorders\" target=\"_blank\">multifactorial</a> cause.[12648] Some studies suggest that the condition may occur due to an abnormal immune response or neurodegeneration (degeneration of certain motor and sensory neurons, specifically).[12648][12649]<br />\r\n<br />\r\nStudies have also shown that <em><a href=\"https://ghr.nlm.nih.gov/gene/SOD1\" target=\"_blank\">SOD1</a></em> and <em><a href=\"https://ghr.nlm.nih.gov/gene/PABPN1\" target=\"_blank\">OPMD</a></em> genes may play a role in FOSMN; however, the specific association is unclear. Although there are currently no familial cases of FOSMN reported in the medical literature, some scientists suspect that newer genetic testing technologies may uncover additional genetic factors.[12648]","dateModified":"2016-11-28T21:09:00","resourceClassificationName":"Cause","references":[{"referenceId":12648,"authors":"Zheng Q1, Chu L, Tan L, Zhang H","articleTitle":"Facial onset sensory and motor neuronopathy","bookWebsiteJournalTitle":"Neurol Sci","date":"December 2016","volume":"37(12)","pages":"1905-1909","url":"","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12649,"authors":"Ziso B, Williams TL, Walters RJ, Jaiser SR, Attems J, Wieshmann UC, Larner AJ, Jacob A","articleTitle":"Facial Onset Sensory and Motor Neuronopathy: Further Evidence for a TDP-43 Proteinopathy","bookWebsiteJournalTitle":"Case Rep Neurol","date":"April 2015","volume":"7(1)","pages":"95-100","url":"","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":11356,"questionText":"Is facial onset sensory and motor neuronopathy inherited?&nbsp;","answerText":"There is currently no evidence to suggest that facial onset sensory and motor neuronopathy is inherited. To date, no familial cases have been reported which means that the condition appears to occur <a href=\"http://www.ncbi.nlm.nih.gov/books/NBK5191/def-item/sporadic/\" target=\"_blank\">sporadically</a> in people with no family history of the condition.[12648]","dateModified":"2016-11-28T21:19:00","resourceClassificationName":"Inheritance","references":[{"referenceId":12648,"authors":"Zheng Q1, Chu L, Tan L, Zhang H","articleTitle":"Facial onset sensory and motor neuronopathy","bookWebsiteJournalTitle":"Neurol Sci","date":"December 2016","volume":"37(12)","pages":"1905-1909","url":"","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":11359,"questionText":"How is facial onset sensory and motor neuronopathy diagnosed?","answerText":"Due to the small number of reported cases, there are no agreed upon diagnostic criteria for facial onset sensory and motor neuronopathy. A diagnosis is often suspected based on the presence of characteristic signs and symptoms. Additional tests may then be ordered to support the diagnosis and rule out other conditions that are associated with similar features. These include:[12648]\r\n<ul>\r\n    <li><a href=\"https://medlineplus.gov/ency/article/003929.htm\" target=\"_blank\">Electromyography</a> and nerve conduction studies</li>\r\n    <li>Laboratory tests</li>\r\n    <li><a href=\"https://medlineplus.gov/ency/article/003428.htm\" target=\"_blank\">Lumbar puncture</a> (spinal tap)</li>\r\n    <li><a href=\"https://medlineplus.gov/ency/article/003335.htm\" target=\"_blank\">MRI</a> of the brain and spinal cord</li>\r\n</ul>","dateModified":"2016-11-29T14:45:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":12648,"authors":"Zheng Q1, Chu L, Tan L, Zhang H","articleTitle":"Facial onset sensory and motor neuronopathy","bookWebsiteJournalTitle":"Neurol Sci","date":"December 2016","volume":"37(12)","pages":"1905-1909","url":"","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":11361,"questionText":"How might facial onset sensory and motor neuronopathy be treated?","answerText":"Due to the rarity of the condition, the best approach for effective treatment is currently unclear. Several treatments have been mentioned in case reports including intravenous immunoglobulin (IVIG), <a href=\"https://www.mda.org/sites/default/files/publications/Facts_Plasmapheresis_P-206.pdf\" target=\"_blank\">plasmapheresis</a> (PE), <a href=\"http://www.nlm.nih.gov/medlineplus/steroids.html\" target=\"_blank\">corticosteroids</a>, <a href=\"https://medlineplus.gov/druginfo/meds/a682167.html\" target=\"_blank\">azathioprine</a>, <a href=\"http://www.rheumatology.org/I-Am-A/Patient-Caregiver/Treatments/Mycophenolate-Mofetil-Mycophenolate-Sodium\" target=\"_blank\">mycophenolate mofetil</a>, and <a href=\"https://medlineplus.gov/druginfo/meds/a607038.html\" target=\"_blank\">rituximab</a>. Although some patients showed temporary improvements with IVIG and PE, the majority of cases did not respond to any of these treatments.[12648]","dateModified":"2016-11-29T15:17:00","resourceClassificationName":"Treatment","references":[{"referenceId":12648,"authors":"Zheng Q1, Chu L, Tan L, Zhang H","articleTitle":"Facial onset sensory and motor neuronopathy","bookWebsiteJournalTitle":"Neurol Sci","date":"December 2016","volume":"37(12)","pages":"1905-1909","url":"","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":8703,"phenoTypeName":"Dysarthria","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13402,"phenoTypeName":"Dysphagia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5156,"phenoTypeName":"Fasciculations","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5588,"phenoTypeName":"Muscle spasm","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9419,"phenoTypeName":"Muscle weakness","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5592,"phenoTypeName":"Paresthesia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14505,"phenoTypeName":"Skeletal muscle atrophy","frequencyText":"Very frequent","percentRanges":"80%-99%"}],"medicalProducts":[],"EncodedName":"Facial_onset_sensory_and_motor_neuronopathy"}